Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.
Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks
For many people with migraine, it can be difficult to find a treatment that is effective and reliable, and information on how medications compare to
November 30, 2023